Takashi Tanaka

Dr. Takashi Tanaka

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in RadioGraphics
Verified
Journal Article
Closed access
DGDaniel B. Green
Daniel B. Green
AKAkira Kawashima
Akira Kawashima
CMChristine O. Menias
Christine O. Menias
TTTakashi Tanaka
Takashi Tanaka
GRGil Redelman-Sidi
Gil Redelman-Sidi
BKBernard F. King
Bernard F. King
The development of bacillus Calmette-Guérin, the role of this organism in adjuvant bladder cancer therapy, and the potential multisystem complications associated with bacillus Calmette-Guérin treatment are reviewed, with imaging correlation. Bladder cancer is the sixth most common cancer in the United States, and 70% of cases are non–muscle invasive. Intravesical bacillus Calmette-Guérin (BCG) immunotherapy, administered after transurethral tumor resection, is the most effective adjuvant treatment for intermediate- and high-grade non–muscle-invasive bladder cancer. Despite its weakened state, BCG has the potential to cause multisystem disease in treated patients. Although minor side effects following BCG administration are common, complications are rare. The pathogenesis of BCG-related disease may be active infection or a hypersensitivity reaction, and complications can involve many organ systems. Local complications result from BCG-contaminated urine and affect the genitourinary system. Systemic complications are the result of BCG dissemination in the bloodstream, and they may be musculoskeletal, vascular, pulmonary, or hepatic or involve other organ systems. Because the imaging findings of BCG-related complications can mimic those of cancer...

1 May 2020 in RadioGraphics
Verified
Journal Article
Closed access
TTTakashi Tanaka
Takashi Tanaka
MYMing Yang
Ming Yang
AFAdam T. Froemming
Adam T. Froemming
ABAlan Bryce
Alan Bryce
RIRyota Inai
Ryota Inai
AKAkira Kawashima
Akira Kawashima
In patients with locally recurrent and metastatic prostate cancer, it is clinically important that radiologists be familiar with the strengths and limitations of imaging modalities for diagnosis an... Relapsing level of prostate-specific antigen (PSA) after initial curative-intent local therapy for organ-confined prostate cancer is often the first sign of recurrence. However, PSA level recurrenc...

5 July 2015 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
TTTakashi Tanaka
Takashi Tanaka
TSTakayoshi Shinya
Takayoshi Shinya
SSShuhei Sato
Shuhei Sato
TMToshiharu Mitsuhashi
Toshiharu Mitsuhashi
KIKoichi Ichimura
Koichi Ichimura
SKSusumu Kanazawa
Susumu Kanazawa

1 February 2018 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
TIT. Iguchi
T. Iguchi
THTakao Hiraki
Takao Hiraki
YMY. Matsui
Y. Matsui
HFH. Fujiwara
H. Fujiwara
JSJ. Sakurai
J. Sakurai
SKS. Kanazawa
S. Kanazawa

1 September 2021 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
TIToshihiro Iguchi
Toshihiro Iguchi
THTakao Hiraki
Takao Hiraki
YMYusuke Matsui
Yusuke Matsui
KTKoji Tomita
Koji Tomita
MUMayu Uka
Mayu Uka
SKSusumu Kanazawa
Susumu Kanazawa

1 March 2016 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
ATA. Tada
A. Tada
TTTakashi Tanaka
Takashi Tanaka
ATA. Takamoto
A. Takamoto
HYHiroyuki Yanai
Hiroyuki Yanai
SSS. Sato
S. Sato
SKS. Kanazawa
S. Kanazawa